- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04007731
New Protein Bar for Physically Active People
Effects of New Protein Bar on Biochemical and Physiological Parameters in Physically Active People
Study Overview
Status
Conditions
Detailed Description
The clinical study will be performed on 10 elite handball players from Slovenia handball club. It will be designed as a crossover study. Half of the participants will consume the new bar for five days and the other half will consume the control bar. After the five-day washout period, the groups will consume the bar which was not consumed in the first period.
At baseline, at the end of every intervention and washout period, the blood samples will be withdrawn, and the body composition will be analyzed.
The analyzed biochemical parameters will be basic serum parameters, such as fasting glucose, total cholesterol, LDL, HDL, triglycerides, aspartate aminotransferase (AST), alanine aminotransferase (ALT), C-reactive protein (CRP), and parameters related to the muscle regeneration and inflammation, such as creatine kinase, lactate dehydrogenase, insulin-like growth factor (IGF), tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), monocyte chemoattractant protein 1 (MCP-1).
In the second part of the study, the acute effect of consuming each bar after training will be tested. Each participant will consume both bars on separate days. The mentioned parameters will be assessed after training and immediately and 3h after bar consumption.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Izola, Slovenia, SI-6310
- University of Primorska, Faculty of Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- daily high-intensity physical activity
Exclusion Criteria:
- smoking, cardiovascular, neurological, skeletal muscle disease, allergies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: High protein, high fibre and creatine load bar (DrRip)
1 new protein bar (260 kcal) after training every day
|
A protein bar or control bar consumption after training every day for 5 days, 5 days wash-out, 5 days second bar consumption
Other Names:
|
ACTIVE_COMPARATOR: Voltage energy bar
1 control commercially available protein bar (260 kcal) after training every day
|
A protein bar or control bar consumption after training every day for 5 days, 5 days wash-out, 5 days second bar consumption
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle mass
Time Frame: 15 days
|
Muscle mass in kilograms will be determined using bioelectrical impedance analysis (BIA).
|
15 days
|
Fat mass
Time Frame: 15 days
|
Fat mass in kilograms will be determined using bioelectrical impedance analysis (BIA).
|
15 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
C-reactive protein
Time Frame: 15 days
|
Serum levels of C-reactive protein (parameter of inflammation) will be analyzed by biochemistry analyzer (Cobass c111).
|
15 days
|
Creatine kinase
Time Frame: 15 days
|
Serum levels of creatine kinase (marker of regeneration) will be analyzed by biochemistry analyzer (Cobass c111).
|
15 days
|
Lactate dehydrogenase
Time Frame: 15 days
|
Serum levels of creatine kinase (marker of regeneration) will be analyzed by biochemistry analyzer (Cobass c111).
|
15 days
|
Tumor necrosis factor alpha
Time Frame: 15 days
|
Serum levels of Tumor necrosis factor alpha (parameter of inflammation) will be analyzed by enzyme linked immunosorbent assays (ELISA).
|
15 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- barsport
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Assistance Publique - Hôpitaux de ParisCompletedDigestive InflammationFrance
-
Pamukkale UniversityCompletedPeriodontal InflammationTurkey
-
Universidade Federal do ParaCompleted
-
KLE Society's Institute of Dental SciencesCompletedRegenerative InflammationIndia
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Singapore National Eye CentreCompletedIntraocular Inflammation in ChildrenSingapore
Clinical Trials on DrRip - high protein, high fibre and creatine load
-
University of StirlingCompleted
-
Edgar National Centre for Diabetes ResearchCompletedInsulin ResistanceNew Zealand
-
Maastricht University Medical CenterCarbohydrate Competence CenterRecruitingInsulin Resistance | PreDiabetes | Overweight and Obesity | Impaired Glucose ToleranceNetherlands
-
USDA Grand Forks Human Nutrition Research CenterCompletedHealthyUnited States
-
St. Boniface HospitalManitoba Agri-Health Research NetworkCompleted
-
Arizona State UniversityTerminatedBlood Pressure | Endothelial Dysfunction | Insulin SensitivityUnited States
-
University of AberdeenRecruitingScot Sweet Study (Interaction of a Non-nutritive Sweetener With a High-fibre Weight Loss Diet) (SSS)Appetitive BehaviorUnited Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Texas A&M UniversityNutraboltCompletedNutritional Supplements